Stemline And Karyopharm Want More Time At EMA

The CHMP Stiil Has Issues Over Filings For Tagraxofusp And Selinexor

 
• By Maureen Kenny
  
Hourglass
Time matters for companies seeking new product approvals • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography